Abstract
The use of plant miscellaneous preparations as an alternative to the treatment of cancer is a reality today due to the massive marketing of natural medicines versus anticancer chemotherapy. Although this situation is controversial and has not led to any significant benefits to patients, plants may play a significant role in the treatment of cancer. Historically, natural leads have evolved to some of the outstanding medicines used nowadays against lung, breast, and ovarian cancers, and leukemia. Natural products are still some of the important sources of new anticancer drugs. The Brazilian flora is considered one of the most diverse in the world, although not many large-scale pharmacological and phytochemical studies have been conducted so far. We present the updated status and results of the research developed by Brazilian research centers on anticancer active substances derived from natural sources, mainly plants from the Brazilian Rain Forests, focusing on their potential effectiveness and difficulties.
Keywords: biodiversity, screening, natural products, Amazon Rain Forest, Atlantic Forest
Anti-Cancer Agents in Medicinal Chemistry
Title: Cytotoxic Molecules from Natural Sources: Tapping the Brazilian Biodiversity
Volume: 6 Issue: 4
Author(s): Ivana Barbosa Suffredini, Antonio Drauzio Varella and Riad Naim Younes
Affiliation:
Keywords: biodiversity, screening, natural products, Amazon Rain Forest, Atlantic Forest
Abstract: The use of plant miscellaneous preparations as an alternative to the treatment of cancer is a reality today due to the massive marketing of natural medicines versus anticancer chemotherapy. Although this situation is controversial and has not led to any significant benefits to patients, plants may play a significant role in the treatment of cancer. Historically, natural leads have evolved to some of the outstanding medicines used nowadays against lung, breast, and ovarian cancers, and leukemia. Natural products are still some of the important sources of new anticancer drugs. The Brazilian flora is considered one of the most diverse in the world, although not many large-scale pharmacological and phytochemical studies have been conducted so far. We present the updated status and results of the research developed by Brazilian research centers on anticancer active substances derived from natural sources, mainly plants from the Brazilian Rain Forests, focusing on their potential effectiveness and difficulties.
Export Options
About this article
Cite this article as:
Barbosa Suffredini Ivana, Drauzio Varella Antonio and Naim Younes Riad, Cytotoxic Molecules from Natural Sources: Tapping the Brazilian Biodiversity, Anti-Cancer Agents in Medicinal Chemistry 2006; 6 (4) . https://dx.doi.org/10.2174/187152006777698187
DOI https://dx.doi.org/10.2174/187152006777698187 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
FLIM-FRET for Cancer Applications
Current Molecular Imaging (Discontinued) Synthesis, Radiosynthesis and Metabolism of 131I-Y-c(CGRRAGGSC)
Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Potential of a Novel SERM Ormeloxifene
Current Medicinal Chemistry Redox mechanisms in pathological angiogenesis in the retina: roles for NADPH oxidase
Current Pharmaceutical Design The Use of DNA Microarrays to Investigate the Pharmacogenomics of Drug Response in Living Systems
Current Topics in Medicinal Chemistry Cisplatin Resistance and Transcription Factors
Current Medicinal Chemistry - Anti-Cancer Agents Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Anti-Cancer Agents in Medicinal Chemistry Overview: Translating Hsp90 Biology into Hsp90 Drugs
Current Cancer Drug Targets Role of Microtubules Network in CYP Genes Expression
Current Drug Metabolism Role of CHK2 Inhibitors in the Cellular Responses to Ionizing Radiation
Mini-Reviews in Medicinal Chemistry Squalamine as an Example of a New Potent Antimicrobial Agents Class: A Critical Review
Current Medicinal Chemistry Solubilization and Antitumor Activity of Oleanolic Acid Lysinate
Current Analytical Chemistry The Role of Oxazolidine Derivatives in the Treatment of Infectious and Chronic Diseases
Current Bioactive Compounds Selenium Compounds and Apoptotic Modulation: A New Perspective in Cancer Therapy
Mini-Reviews in Medicinal Chemistry microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology C-glycosyl Flavone from Urginea indica Inhibits Growth and Dissemination of Ehrlich Ascites Carcinoma Cells in Mice
Anti-Cancer Agents in Medicinal Chemistry Effect of Intestinal Flora Clearance on Liver Proteomics in Mice
Current Proteomics Functionalized Nanocarriers for Enhanced Bioactive Delivery to Squamous Cell Carcinomas: Targeting Approaches and Related Biopharmaceutical Aspects
Current Pharmaceutical Design Synthesis of 2,5-Disubstituted-1,3,4-oxadiazole Analogs as Novel Anticancer and Antimicrobial Agents
Letters in Drug Design & Discovery Pharmacogenomics of COPD
Current Pharmacogenomics